摘要
肿瘤复发和耐药性是影响癌症患者预后的两个关键因素。癌症干细胞(CSC)是一组具有无限增殖潜能的细胞,它们对包括放射疗法和化学疗法在内的传统疗法不敏感。这些CSC被认为是肿瘤复发和耐药性发展的关键。另外,由于CSCs表达新的肿瘤相关抗原,CSCs是癌症免疫治疗中的重要靶标,这是由于在治疗过程中癌细胞的突变所致。新兴的免疫疗法,包括癌症疫苗,检查站封锁疗法和转移的免疫细胞疗法,已被证明在选择性靶向CSC时更为有效。这样的疗法还可以为当前的治疗环境提供新颖的补充,并且可以为治疗提供新的治疗组合。这篇综述总结了各种免疫疗法和CSCs之间的关系,并为这些方法在未来的潜在治疗应用中提供了新颖的见解。
关键词: 免疫疗法,癌症干细胞,治疗应用,临床,目标,机制。
图形摘要
Current Cancer Drug Targets
Title:Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells
Volume: 21 Issue: 2
关键词: 免疫疗法,癌症干细胞,治疗应用,临床,目标,机制。
摘要: Tumor recurrence and drug resistance are two of the key factors affecting the prognosis of cancer patients. Cancer stem cells (CSCs) are a group of cells with infinite proliferation potential which are not sensitive to traditional therapies, including radio- and chemotherapy. These CSCs are considered to be central to tumor recurrence and the development of drug resistance. In addition, CSCs are important targets in cancer immunotherapy because of their expression of novel tumorassociated antigens, which result from mutations in cancer cells over the course of treatment. Emerging immunotherapies, including cancer vaccines, checkpoint blockade therapies, and transferred immune cell therapies, have all been shown to be more effective when they selectively target CSCs. Such therapies may also provide novel additions to the current therapeutic milieu and may offer new therapeutic combinations for treatment. This review summarizes the relationships between various immunotherapies and CSCs and provides novel insights into potential therapeutic applications for these approaches in the future.
Export Options
About this article
Cite this article as:
Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells, Current Cancer Drug Targets 2021; 21 (2) . https://dx.doi.org/10.2174/1568009620666200504111914
DOI https://dx.doi.org/10.2174/1568009620666200504111914 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Status of Flavonols as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Current Cancer Therapy Reviews Secondary Radiation-Induced Bone Tumours Demonstrate a High Degree of Genomic Instability Predictive of a Poor Prognosis
Current Genomics Intrinsic Disorder in Male Sex Determination: Disorderedness of Proteins from the Sry Transcriptional Network
Current Protein & Peptide Science Colorectal Cancer-Associated Fibroblasts are Genotypically Distinct
Current Cancer Therapy Reviews HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Mini-Reviews in Medicinal Chemistry Isoform-Selective PI3K Inhibitors for Various Diseases
Current Topics in Medicinal Chemistry Substance Abuse, HIV-1 and Hepatitis
Current HIV Research Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Neuropeptide Y and Cancer Anorexia
Current Medicinal Chemistry - Central Nervous System Agents Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy New Insights into Biological Markers of Frontotemporal Lobar Degeneration Spectrum
Current Medicinal Chemistry How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes?
Current Women`s Health Reviews Cancer Vaccines: Emphasis on Pediatric Cancers
Current Pharmaceutical Design CD147 Promotes Melanoma Progression Through Hypoxia-Induced MMP2 Activation
Current Molecular Medicine Antisense Technologies Targeting Fatty Acid Synthetic Enzymes
Recent Patents on Anti-Cancer Drug Discovery The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)
Recent Patents on Inflammation & Allergy Drug Discovery Liposome-Nanogel Structures for Future Pharmaceutical Applications
Current Pharmaceutical Design Sinonasal Carcinoma: Updated Phenotypic and Molecular Characterization
Current Cancer Therapy Reviews Acetylenic Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry